Biometana - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 18,745 | 241,605 | 202,201 | 358,433 | 272,612 | 371,883 | 821,339 |
| Profit before tax | -26,984 | -78,010 | 53,325 | -300,498 | -355,032 | 3,066,887 | -397,054 | 20,483 |
| Net profit | -26,984 | -78,010 | 53,325 | -300,498 | -355,032 | 2,787,852 | -397,054 | 19,500 |
| Equity | -26,634 | -104,644 | -51,319 | -351,818 | 836,707 | 3,422,751 | 2,703,890 | 2,481,825 |
| Liabilities | 133,952 | 2,678,695 | 2,788,400 | 2,474,733 | 2,569,596 | 7,013,704 | 5,062,688 | 4,872,542 |
| Non-current assets | 0 | 2,519,852 | 3,461,917 | 3,279,792 | 4,428,394 | 10,557,577 | 7,422,136 | 7,031,132 |
| Current assets | 107,318 | 54,199 | 837,345 | 204,105 | 137,691 | 830,667 | 1,088,091 | 866,509 |
| Total assets | 107,318 | 2,574,051 | 4,299,262 | 3,483,897 | 4,566,085 | 11,388,244 | 8,510,227 | 7,897,641 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 41,067 | 316,058 | 76,495 |
| Social insurance contributions | - | - | - | - | - | 17,132 | 17,255 | 17,953 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +1188.9% | -16.3% | +77.3% | -23.9% | +36.4% | +120.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -25.1% | -3.0% | 1.2% | -8.6% | -7.8% | 24.5% | -4.7% | 0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | -42.4% | 81.5% | -14.7% | 0.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -416.2% | 22.1% | -148.6% | -99.1% | 1022.6% | -106.8% | 2.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -416.2% | 22.1% | -148.6% | -99.1% | 1125.0% | -106.8% | 2.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 3.1 | 2.0 | 1.9 | 2.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 9,373 | 85,273 | 48,528 | 86,023 | 68,153 | 92,971 | 205,335 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biometana - Social security debts
The amount of overdue SODRA debt for the company Biometana as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-20 | 2026-09-20 | 0.01 |
| 2026-09-16 | 2026-09-17 | 0.01 |
| 2026-08-26 | 2026-08-31 | 0.01 |
| 2026-08-23 | 2026-08-23 | 0.01 |
| 2026-08-19 | 2026-08-19 | 0.01 |
| 2026-07-19 | 2026-08-02 | 0.01 |
| 2026-07-16 | 2026-07-17 | 0.01 |
| 2026-06-16 | 2026-06-30 | 0.01 |
| 2026-05-03 | 2026-05-03 | 0.01 |
| 2026-04-20 | 2026-04-29 | 0.01 |
| 2026-03-29 | 2026-03-31 | 0.01 |
| 2026-03-17 | 2026-03-27 | 0.01 |
| 2026-02-18 | 2026-03-01 | 0.01 |
| 2026-01-16 | 2026-02-01 | 0.01 |
| 2025-12-16 | 2025-12-29 | 0.01 |
| 2025-11-18 | 2025-11-30 | 0.01 |
| 2025-10-16 | 2025-11-02 | 0.01 |
| 2025-09-16 | 2025-09-30 | 0.01 |
| 2025-08-31 | 2025-08-31 | 0.01 |
| 2025-08-19 | 2025-08-29 | 0.01 |
| 2025-07-16 | 2025-07-31 | 0.01 |
| 2025-06-17 | 2025-06-30 | 0.01 |
| 2025-05-16 | 2025-06-01 | 0.01 |
| 2025-04-16 | 2025-04-30 | 0.01 |
| 2025-03-18 | 2025-03-31 | 0.01 |
| 2025-02-18 | 2025-03-03 | 0.01 |
| 2025-02-10 | 2025-02-10 | 0.01 |
| 2025-01-22 | 2025-02-02 | 0.01 |
| 2024-03-18 | 2024-03-25 | 14.06 |
| 2024-02-19 | 2024-02-29 | 14.06 |
| 2024-01-23 | 2024-01-31 | 14.06 |
| 2023-11-27 | 2023-12-06 | 1471.33 |
| 2023-11-16 | 2023-11-26 | 1759.50 |
| 2023-10-17 | 2023-10-22 | 1637.10 |
| 2023-03-16 | 2023-04-10 | 1.19 |
| 2023-02-17 | 2023-03-05 | 1.19 |
| 2023-01-23 | 2023-02-01 | 1.19 |
| 2022-10-18 | 2022-10-19 | 1326.43 |
| 2022-07-18 | 2022-07-21 | 0.67 |
| 2022-06-16 | 2022-06-30 | 0.67 |
| 2022-05-17 | 2022-06-05 | 0.67 |
| 2022-04-25 | 2022-05-03 | 0.67 |
| 2022-02-03 | 2022-02-27 | 12.43 |
Biometana - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-30 | 2026-08-26 | 0.09 |
| 2026-06-28 | 2026-07-07 | 0.09 |
| 2026-04-30 | 2026-05-25 | 0.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biometana, UAB (code 304414973) is a private limited liability company engaged in gas manufacture. In 2025, the latest financial year, revenue increased to €821.3K, up 120.9% year on year and 201.3% over two years. The company returned to profitability with net profit of €19.5K, after a net loss of €397.1K in 2024. In 2023, revenue was only €272.6K, while profit was unusually high relative to turnover, reflecting a very low revenue base. Over the three-year period, revenue expanded strongly, but profitability weakened sharply in 2024 before stabilising in 2025. The 2025 profit margin was 2.4%, with ROE at 0.8% and ROA at 0.2%, indicating modest returns. Total assets stood at €7.90M, down from €8.51M in 2024 and €11.39M in 2023. Equity was €2.48M and liabilities €4.87M, giving an equity ratio of 31.4% and debt-to-equity of 1.96. Asset turnover remained low at 0.10x. Revenue per employee was €205.3K, with profit per employee of €4.9K.